Cannabinoids: A New Group of Agonists of PPARs
Cannabinoids have been used medicinally and recreationally for thousands of years and their effects were proposed to occur mainly via activation of the G-protein-coupled receptor CB1/CB2 (cannabinoid receptor 1/2). Discovery of potent synthetic analogs of the natural cannabinoids as clinically usefu...
Saved in:
Main Authors: | Yan Sun, Andy Bennett |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2007/23513 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
by: Zhanjun Jia, et al.
Published: (2014-01-01) -
PPAR Agonists and Cardiovascular Disease in Diabetes
by: Anna C. Calkin, et al.
Published: (2008-01-01) -
AMPK-Dependent Metabolic Regulation by PPAR Agonists
by: Woo Hyung Lee, et al.
Published: (2010-01-01) -
PPAR Agonists for the Prevention and Treatment of Lung Cancer
by: Sowmya P. Lakshmi, et al.
Published: (2017-01-01) -
PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
by: Neerupma Silswal, et al.
Published: (2012-01-01)